Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.385
-0.145 (-5.73%)
At close: May 29, 2026, 4:00 PM EDT
2.400
+0.015 (0.63%)
After-hours: May 29, 2026, 7:30 PM EDT
Adial Pharmaceuticals Employees
Adial Pharmaceuticals had 5 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,554,152
Market Cap
3.43M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 5 | 0 | - | 5 | 0 |
| Dec 31, 2024 | 5 | 1 | 25.00% | 5 | 0 |
| Dec 31, 2023 | 4 | -16 | -80.00% | 4 | 0 |
| Dec 31, 2022 | 20 | -1 | -4.76% | 16 | 4 |
| Dec 31, 2021 | 21 | 12 | 133.33% | 16 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| GRI Bio | 4 |
ADIL News
- 18 days ago - Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Adial Pharmaceuticals files AD04 utility application with USPTO - TheFly
- 4 weeks ago - Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 - GlobeNewsWire
- 4 weeks ago - Adial submits AD04 product application for FDA CNPV pilot program - TheFly
- 4 weeks ago - Adial Pharmaceuticals Submits Application to FDA Commissioner's National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program - GlobeNewsWire
- 5 weeks ago - Adial Pharmaceuticals completes AD04 demonstration batch production - TheFly
- 5 weeks ago - Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial - GlobeNewsWire
- 3 months ago - Adial Pharmaceuticals expects cash to fund operations into 2H of 2026 - TheFly